Increased anergic B cells and decreased antibody‐secreting cells during romiplostim treatment in patients with immune thrombocytopenia
British Journal of Haematology · 2026-11 · 209 (5) · 2223-2232
DOI: 10.1111/bjh.70762 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 21.08.2026. Verfasst von Vivianne S Nelson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Sanquin Blood Supply Foundation, Department Research, Amsterdam UMC Location University of Amsterdam, Landsteiner Laboratory, Amsterdam, The Netherla…. Hauptthemen laut MEDLINE: Thrombopoietin, Purpura, Thrombocytopenic, Idiopathic, Receptors, Fc, Recombinant Fusion Proteins. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sanquin Product and Process Development.
Abstract (Originalsprache)
Patients with immune thrombocytopenia (ITP) exhibit substantial heterogeneity in treatment responses. Approximately 30%–50% of patients maintain remission after discontinuation of thrombopoietin receptor agonists (TPO‐RA), suggesting immunomodulatory effects beyond enhanced thrombopoiesis. However, predictive or explanatory biomarkers for sustained remission after TPO‐RA are currently lacking. In this study, we performed spectral flow cytometry on B cells of longitudinal samples from patients before, during and after treatment with the TPO‐RA romiplostim. We observed that anergic B cells were the predominant B cell population within the peripheral blood in romiplostim‐naïve patients (mean: 51.7%) and in healthy controls (mean: 47.8%). Paired longitudinal analyses showed a significant increase in anergic B cells during romiplostim treatment, with values exceeding those of healthy controls after 1 year of treatment (mean: 58.4%, p = 0.006). After tapering, the anergic B cells remained stably increased (mean: 59.7%), both in treatment‐free patients as well as patients who restarted romiplostim. Within the switched‐ and antibody‐secreting cell (ASC) compartment, a decrease of immunoglobulin G (IgG + ) and immunoglobulin A (IgA + ) ASC was observed during romiplostim ( p = 0.04 and p = 0.08). These results reveal a previously unappreciated potential role for anergic B cells and ASCs in ITP and emphasize the need for further investigations of TPO‐RA‐induced B cell responses in ITP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sanquin Blood Supply Foundation, Department Research, Amsterdam UMC Location University of Amsterdam, Landsteiner Laboratory, Amsterdam, The Netherlands.
- Department of Hematology, Haga Teaching Hospital, the Hague, The Netherlands.
- Department of Hematology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
- Amsterdam Institute for Immunology and Infectious Diseases, Amsterdam, The Netherlands.
- Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: Vivianne S Nelson, Rebeca Gutiérrez-Cózar, Rebecca Cornelis, Anja Ten Brinke, Rick Kapur
Förderung
- Sanquin Product and Process Development
Zitieren
APA
Nelson, V. S., Gutiérrez-Cózar, R., Cornelis, R., van Ham, S. M., Ten Brinke, A., & Kapur, R. (2026). Increased anergic B cells and decreased antibody‐secreting cells during romiplostim treatment in patients with immune thrombocytopenia. British Journal of Haematology, 209(5), 2223-2232. https://doi.org/10.1111/bjh.70762
Vancouver
Nelson VS, Gutiérrez-Cózar R, Cornelis R, van Ham SM, Ten Brinke A, Kapur R. Increased anergic B cells and decreased antibody‐secreting cells during romiplostim treatment in patients with immune thrombocytopenia. British Journal of Haematology. 2026;209(5):2223-2232. doi:10.1111/bjh.70762
BibTeX
@article{Nelson2026,
author = {Nelson, Vivianne S and Gutiérrez-Cózar, Rebeca and Cornelis, Rebecca and van Ham, S Marieke and Ten Brinke, Anja and Kapur, Rick},
title = {Increased anergic B cells and decreased antibody‐secreting cells during romiplostim treatment in patients with immune thrombocytopenia},
journal = {British Journal of Haematology},
year = {2026},
volume = {209},
number = {5},
pages = {2223--2232},
doi = {10.1111/bjh.70762}
}
EUVIMED